Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.6K
Seizures: Classification01:13

Seizures: Classification

1.9K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Socioeconomic status and epilepsy surgery in the United States: Timing and outcomes.

Epilepsia·2026
Same author

Information needs of patients considering epilepsy surgery: A scoping review.

Epilepsia·2026
Same author

Moving artificial intelligence from research to real-world clinical use in neurology.

Nature reviews. Neurology·2026
Same author

Zorevunersen in Children and Adolescents with Dravet Syndrome. Reply.

The New England journal of medicine·2026
Same author

Smartphone videos for infantile epileptic spasms triaging and assessment (VISTA study): Impact of education and standardized clinical history on diagnostic accuracy.

Epilepsia open·2026
Same author

Fully automated three-dimensional deep learning-based magnetic resonance imaging segmentation of brain cavities in epilepsy surgery.

Epilepsia·2026

Related Experiment Video

Updated: Mar 3, 2026

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.4K

AES ILAE North America Symposium: Guiding Evidence-Based Epilepsy Management.

Nathalie Jette1, Kette Valente2, Nicholas S Abend3

  • 1Department of Clinical Neurosciences, University of Calgary, Calgary, Canada.

Epilepsy Currents
|March 2, 2026
PubMed
Summary

This review covers recent clinical practice guidelines (CPG) and consensus-based recommendations (CBR) for epilepsy care, focusing on genetic testing, neonatal seizures, pediatric depression, and epilepsy surgery. These guidelines impact patient outcomes and inform best practices.

Keywords:
Delphiclinical practice standardconsensus-based recommendationsguidelineseizure

More Related Videos

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

18.3K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.6K

Related Experiment Videos

Last Updated: Mar 3, 2026

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring
11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

1.4K
Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

18.3K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.6K

Area of Science:

  • Neurology
  • Clinical Practice Guidelines
  • Evidence-Based Medicine

Background:

  • Clinical practice guidelines (CPG) and consensus-based recommendations (CBR) are crucial for evidence-based patient care.
  • Rigorous development involves systematic reviews and evidence evaluation.
  • CPG and CBR are vital for informing best practices and health policy.

Purpose of the Study:

  • To review recent epilepsy-specific CPG and CBR.
  • To highlight guidelines concerning genetic testing, neonatal seizures, pediatric depression, and epilepsy surgery referral timing.
  • To assess the impact of these recommendations on patient outcomes.

Main Methods:

  • Literature review of recent epilepsy CPG and CBR.
  • Analysis of guideline development processes.
  • Evaluation of reported impacts on patient outcomes.

Main Results:

  • Recent guidelines address key areas in epilepsy management including genetic testing and neonatal seizures.
  • Consensus-based recommendations are utilized when evidence is limited.
  • Guidelines cover pediatric depression and optimal timing for epilepsy surgery referrals.

Conclusions:

  • Epilepsy CPG and CBR are essential tools for optimizing patient care and informing health policy.
  • These recommendations guide clinical decision-making in complex epilepsy cases.
  • Further research may be needed to fully elucidate the impact of these guidelines on outcomes.